Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-25-252843
Filing Date
2025-10-28
Accepted
2025-10-28 11:28:39
Documents
10
Period of Report
2025-08-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A neog-20250814.htm   iXBRL 8-K/A 44139
  Complete submission text file 0001193125-25-252843.txt   152849

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20250814.xsd EX-101.SCH 25946
12 EXTRACTED XBRL INSTANCE DOCUMENT neog-20250814_htm.xml XML 5081
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K/A | Act: 34 | File No.: 000-17988 | Film No.: 251422297
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)